PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases
A functional single nucleotide polymorphism (SNP) C1858T in the protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene encoding an intracellular phosphatase with negative regulatory effects on T-cell activation is associated with some autoimmune diseases in Caucasians. Taking into account firstly...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2005
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24138
- Acceso en línea:
- https://doi.org/10.1038/sj.gene.6364261
https://repository.urosario.edu.co/handle/10336/24138
- Palabra clave:
- Protein tyrosine phosphatase
Protein tyrosine phosphatase nonreceptor 22
Unclassified drug
Article
Autoimmune disease
Autoimmunity
Caucasian
Colombia
Controlled study
Dna polymorphism
Gene frequency
Gene replication
Genetic code
Genotype
Human
Immunogenetics
Insulin dependent diabetes mellitus
Intracellular space
Major clinical study
Phenotype
Priority journal
Real time polymerase chain reaction
Rheumatoid arthritis
Risk factor
Single nucleotide polymorphism
Sjoegren syndrome
Systemic lupus erythematosus
T lymphocyte activation
Adult
Aged
Alleles
Autoimmune diseases
Colombia
European continental ancestry group
Female
Humans
Male
Middle aged
Protein-tyrosine-phosphatase
Sjogren's syndrome
Colombia
Diabetes mellitus
Ptpn22
Rheumatoid arthritis
Sjögren's syndrome
Systemic lupus erythematosus
single nucleotide
rheumatoid
type 1
systemic
Arthritis
Diabetes mellitus
Lupus erythematosus
Polymorphism
- Rights
- License
- Abierto (Texto Completo)
Summary: | A functional single nucleotide polymorphism (SNP) C1858T in the protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene encoding an intracellular phosphatase with negative regulatory effects on T-cell activation is associated with some autoimmune diseases in Caucasians. Taking into account firstly, that SNP frequencies may vary across populations and, secondly, that replication studies are important to confirm previous associations, we examined the influence of PTPN22 polymorphism in 621 Colombian patients with four autoimmune diseases. Accordingly, 298 patients with rheumatoid arthritis (RA), 143 with systemic lupus erythematosus (SLE), 70 with primary Sjogren's syndrome (pSS) and 110 with Type 1 diabetes (T1D) were studied. The control group consisted of 308 matched healthy individuals. Genotyping of PTPN22 was performed by the real-time polymerase chain reaction technology, using the TaqMan 5?-allele discrimination assay. The 1858 T allele was found to be a risk factor for pSS (odds ratio (OR)=2.42), SLE (OR=2.56), and T1D (OR =1.83). A lower but nonsignificant trend was observed for RA (OR=1.26). These results confirm the influence of PTPN22 in autoimmunity and indicate that autoimmune phenotypes could represent pleiotropic outcomes of nonspecific disease genes that underlie similar immunogenetic mechanisms. © 2005 Nature Publishing Group. All rights reserved. |
---|